HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23184486
PubMed Central
PMC3683150
DOI
10.1007/s12223-012-0213-7
Knihovny.cz E-zdroje
- MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci * MeSH
- genotyp MeSH
- HLA-C antigeny genetika MeSH
- HLA-DQ beta řetězec genetika MeSH
- HLA-DRB1 řetězec genetika MeSH
- lidé MeSH
- polymerázová řetězová reakce MeSH
- psoriáza genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Slovenská republika MeSH
- Názvy látek
- HLA-C antigeny MeSH
- HLA-DQ beta řetězec MeSH
- HLA-DQB1 antigen MeSH Prohlížeč
- HLA-DRB1 řetězec MeSH
Psoriasis vulgaris is a complex chronic skin disease with immunological and genetic background. The most important predisposing genetic factors in psoriasis are genes of the human leukocyte antigen (HLA) region. Accumulative evidence has shown that several HLA alleles are closely associated with psoriasis; however, they tend to vary in different racial and ethnic backgrounds. One hundred forty-seven unrelated Slovak patients with psoriasis vulgaris (average age at onset 28 ± 14 years) were genotyped for the HLA-C, DQB1 and DRB1 alleles by the polymerase chain reaction using sequence-specific primers. Allele frequencies observed in the group of psoriatic patients were compared to those obtained in the ethnically matched control group comprising 194 subjects with no history of psoriasis. Susceptibility to psoriasis vulgaris in our study group is significantly associated with HLA-C*06 (odds ratio (OR) = 3.85), DRB1*07 (OR = 2.56) and DQB1*02 (OR = 1.09), respectively, whereas DRB*01 (OR = 0.05) is associated negatively. Hereby, we provide the first report on the association of HLA-C, DRB1 and DQB1 alleles with psoriasis in the Slovak population. Our findings confirm HLA-C*06 and DRB1*07 as the most important genetic risk factors for psoriasis. However, the role of HLA genes as causative in the pathogenesis of the disease remains unclear. Identification of genetic factors that increase the risk of psoriasis is a precondition that helps to elucidate the pathogenesis of this troubling disease and identify targets for a more specific and effective therapy.
Department of Immunology Comenius University School of Medicine Nám odborárov 14 Bratislava Slovakia
Zobrazit více v PubMed
Asahina A, Kuwata S, Tongunaga K, et al. Study of aspartate at residue 9 of HLA-C molecules in Japanese patients with psoriasis vulgaris. J Dermatol Sci. 1996;13:125–133. doi: 10.1016/S0923-1811(96)00518-X. PubMed DOI
Brenner W, Gschnait F, Mayr RW. HLAs B13, B17, B37 and Cw6 in psoriasis vulgaris: association with age of onset. Arch Dermatol Res. 1978;262:337–339. doi: 10.1007/BF00447371. PubMed DOI
Bunce M, Barnardo MCNM, Procter J, et al. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens. 1996;48:680–691. doi: 10.1111/j.1399-0039.1996.tb02692.x. PubMed DOI
Capon F, Munro M, Barker J, Trembath R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol. 2002;118:745–771. doi: 10.1046/j.1523-1747.2002.01749.x. PubMed DOI
Capon F, Toal IK, Evans JC, et al. Haplotype analysis of distantly related populations implicates corneodesmosin in psoriasis susceptibility. J Med Genet. 2003;40:447–452. doi: 10.1136/jmg.40.6.447. PubMed DOI PMC
Cassia FF, Carneiro SC, Marques MTQ, et al. Psoriasis vulgaris and human leukocyte antigens. J Eur Acad Dermatol Venereol. 2007;21:303–310. doi: 10.1111/j.1468-3083.2006.02008.x. PubMed DOI
Cechova E, Fazekasova H, Ferencik S, Shawkatova I, Buc M. HLA-DRB1, -DQB1 and -DPB1 polymorphism in the Slovak population. Tissue Antigens. 1998;51:574–576. doi: 10.1111/j.1399-0039.1998.tb02996.x. PubMed DOI
Choonhakarn C, Romphruk A, Puapairoj C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int J Dermatol. 2002;41:330–334. doi: 10.1046/j.1365-4362.2002.01496.x. PubMed DOI
Elder JT, Nair RP, Voorhees JJ. Epidemiology and the genetics of psoriasis. J Invest Dermatol. 1994;102:24–27. doi: 10.1111/1523-1747.ep12386091. PubMed DOI
Elder JT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol. 2001;137:1447–1454. PubMed
Henseler T. The genetics of psoriasis. Arch Dermatol Res. 1998;290:463–476. doi: 10.1007/s004030050338. PubMed DOI
Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;3:450–456. doi: 10.1016/S0190-9622(85)70188-0. PubMed DOI
Kastelan M, Gruber F, Cecuk-Jelicic E, et al. A new extended haplotype Cw*0602-B57-DRB1*0701-DQA1*0201-DQB1*0201 associated with psoriasis in the Croatian population. Clin Exp Dermatol. 2003;28:200–202. doi: 10.1046/j.1365-2230.2003.01215.x. PubMed DOI
Kulcsarova E, Buc M, Ferencik S. HLA-A, HLA-B and HLA-C polymorphism in the Slovak population. Folia Biologica (Praha) 2000;46:153–156. PubMed
Kundakci N, Oskay T, Olmez U, et al. Association of psoriasis vulgaris with HLA class I and class II antigens in the Turkish population, according to the age at onset. Int J Dermatol. 2002;41:345–348. doi: 10.1111/j.1365-4632.2002.01458.x. PubMed DOI
Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60:218–224. doi: 10.1016/j.jaad.2008.09.022. PubMed DOI PMC
Luszczek W, Kubicka W, Cislo M, et al. Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients. Immunol Lett. 2003;85:59–64. doi: 10.1016/S0165-2478(02)00212-2. PubMed DOI
Martinez-Borra J, Gonzalez S, Santos-Juanes J, et al. Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology. 2003;42:1089–1092. doi: 10.1093/rheumatology/keg304. PubMed DOI
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction of high molecular weight DNA from human nucleated cells. Nucl Acids Res. 1998;16:1215. doi: 10.1093/nar/16.3.1215. PubMed DOI PMC
Nair RP, Stuart P, Henseler T, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000;66:1833–1834. doi: 10.1086/302932. PubMed DOI PMC
O’Brien KP, Holm SJ, Nilsson S, et al. The HCR gene on 6p21 is unlikely to be a psoriasis susceptibility gene. J Invest Dermatol. 2001;116:750–754. doi: 10.1046/j.0022-202x.2001.01323.x. PubMed DOI
Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 h An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225–235. doi: 10.1111/j.1399-0039.1992.tb01940.x. PubMed DOI
Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 h. Tissue Antigens. 1993;41:119–134. doi: 10.1111/j.1399-0039.1993.tb01991.x. PubMed DOI
Orru S, Giuressi E, Carcassi C, et al. Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN) Am J Hum Genet. 2005;76:164–171. doi: 10.1086/426948. PubMed DOI PMC
Pasic A, Lipozencic J, Ceovic R, Kostovic K. The genetics of psoriasis—selected novelties in 2008. Acta dermatovenerologica Croatica. 2009;17:176–181. PubMed
Roitberg-Tambur A, Friedman A, Tzfoni EE, et al. Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? J Am Acad Dermatol. 1994;31:964–968. doi: 10.1016/S0190-9622(94)70265-9. PubMed DOI
Russel JT, Schultes ML, Kuban DJ. Histocompatibility antigens associated with psoriasis. N Engl J Med. 1972;287:738–739. doi: 10.1056/NEJM197210122871503. PubMed DOI
Schmitt-Egenolf M. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol. 1996;106:711–714. doi: 10.1111/1523-1747.ep12345600. PubMed DOI
Szczerkowska-Dobosz A. Human leukocyte antigens as psoriasis inheritance and susceptibility markers. Arch Immunol Ther Exp (Warsz) 2005;53:428–433. PubMed
Szczerkowska-Dobosz A, Placek W, Szczerkowska Z, et al. Psoriasis vulgaris with the early and late onset-HLA phenotype correlations. Arch Immunol Ther Exp (Warsz) 1996;44:265–269. PubMed
Szczerkowska-Dobosz A, Rebala K, Szczerkowska Z, Witkowska-Tobola A. Correlation of HLA-Cw*06 allele frequency with some clinical features of psoriasis vulgaris in the population of nothern Poland. J Appl Genet. 2004;45:473–476. PubMed
Tazi-Ahnini R, Camp NJ, Cork MJ, et al. Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum Mol Genet. 1999;8:1135–1140. doi: 10.1093/hmg/8.6.1135. PubMed DOI
Weger W. Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. Br J Pharmacol. 2010;160:810–820. doi: 10.1111/j.1476-5381.2010.00702.x. PubMed DOI PMC